Expert Insights Into Optimal Outpatient Management of Acute and Long COVID

Assessment of symptoms and comorbidities is important for developing individualized care plans for patients with long COVID.

Fernando Carnavali, MD Rasika Karnik, MS, MD Renslow Sherer, MD Released: October 11, 2022

Read our answers to key issues about SARS-CoV-2 testing and patient-specific risk stratification for determining COVID-19 treatment.

Renslow Sherer, MD
Program Director Rasika Karnik, MS, MD Released: December 20, 2022

Read my answers to key issues about treatment recommendations and drug therapy considerations for nonhospitalized patients with acute COVID-19.

Joseph Torrisi, PharmD, BCIDP Released: November 17, 2022

Read our answers to key issues about the individualized management of patients experiencing long COVID.

Fernando Carnavali, MD Renslow Sherer, MD Released: December 13, 2022

Learn from one patient about the challenges with long COVID and what she would like healthcare professionals to know about her experiences.

Robin Gorna Released: January 5, 2023

Listen as expert faculty discuss new COVID-19 vaccines and how they may affect risk stratification of individuals infected with SARS-CoV-2.

Fernando Carnavali, MD Renslow Sherer, MD Joseph Torrisi, PharmD, BCIDP Released: December 27, 2022

Listen as expert faculty discuss the ethical prioritization of patients for COVID-19 treatment when treatment supplies are limited.

Fernando Carnavali, MD Rasika Karnik, MS, MD Renslow Sherer, MD Joseph Torrisi, PharmD, BCIDP Released: December 29, 2022

Listen as expert faculty discuss COVID-19 rebound, related to and independent of COVID-19 antiviral treatment.

Fernando Carnavali, MD Rasika Karnik, MS, MD Renslow Sherer, MD Joseph Torrisi, PharmD, BCIDP Released: December 30, 2022

Listen as expert faculty discuss resistance to COVID-19 antiviral treatments.

Renslow Sherer, MD
Program Director Fernando Carnavali, MD Rasika Karnik, MS, MD Joseph Torrisi, PharmD, BCIDP Released: January 4, 2023

Listen as expert faculty discuss strategies for long COVID prevention and treatment and the challenging aspects of managing patients with long COVID.

Renslow Sherer, MD
Program Director Fernando Carnavali, MD Rasika Karnik, MS, MD Released: January 4, 2023

In this on-demand webcast from a live symposium at IDWeek 2022, expert faculty discuss COVID-19 testing, diagnosis, and risk stratification; COVID-19 therapeutic options for nonhospitalized patients; and long COVID.

Renslow Sherer, MD
Program Director Fernando Carnavali, MD Rasika Karnik, MS, MD Joseph Torrisi, PharmD, BCIDP Physicians: maximum of 2.0 AMA PRA Category 1 Credits™ Pharmacists: 2.0 contact hours (0.2 CEUs) Released: December 12, 2022 Expired: No longer available for credit

Introduction

COVID-19 Testing, Diagnosis, and Risk Stratification

Treatments for Acute COVID-19 in Nonhospitalized Patients

Long COVID

Question and Answer Session

Read expert faculty member summaries of COVID-19 diagnosis, testing, and risk stratification; treatment guidelines and treatment selection (including antivirals and monoclonal antibodies) for nonhospitalized patients; and long COVID.

Renslow Sherer, MD
Program Director Fernando Carnavali, MD Rasika Karnik, MS, MD Joseph Torrisi, PharmD, BCIDP Released: October 25, 2022